Your browser doesn't support javascript.
loading
Sensorineural hearing loss (SNHL) as an adverse event following immunization (AEFI): Case definition & guidelines for data collection, analysis, and presentation of immunization safety data.
Carol Liu, Yi-Chun; Ibekwe, Titus; Kelso, John M; Klein, Nicola P; Shehu, Nathan; Steuerwald, Wendy; Aneja, Satinder; Dudley, Matthew Z; Garry, Robert; Munoz, Flor M.
Afiliação
  • Carol Liu YC; Department of Otorhinolaryngology, Baylor College of Medicine and Texas Children's Hospital, Houston, TX, USA.
  • Ibekwe T; Department of Otorhinolaryngology, University of Abuja, Nigeria.
  • Kelso JM; Division of Allergy, Asthma and Immunology, Scripps Clinic, San Diego, CA, USA.
  • Klein NP; Kaiser Permanente Vaccine Study Center, Oakland, CA, USA.
  • Shehu N; Department of Pediatric Infectious Diseases, Jos University, Nigeria.
  • Steuerwald W; Department of Audiology, Phoenix Children's Hospital, Phoenix, AZ, USA.
  • Aneja S; Department of Pediatrics, School of Medical Sciences and Research, Sharda University, Gr Noida, India.
  • Dudley MZ; Department of International Health, and Institute for Vaccine Safety, Johns Hopkins University Bloomberg School of Public Health, Baltimore, MD, USA.
  • Garry R; Tulane University, Louisiana, USA.
  • Munoz FM; Department of Pediatrics, Section of Infectious Diseases, and Department of Molecular Virology and Microbiology, Baylor College of Medicine, Houston, TX, USA. Electronic address: bc-coordinator@taskforce.org.
Vaccine ; 38(30): 4717-4731, 2020 06 19.
Article em En | MEDLINE | ID: mdl-32418788
ABSTRACT
This is a Brighton Collaboration case definition of the term "Sensorineural Hearing Loss" to be utilized in the evaluation of adverse events following immunization. The case definition was developed by a group of experts convened by the Coalition for Epidemic Preparedness Innovations (CEPI) in the context of active development of vaccines for Lassa Fever and other emerging pathogens. The case definition format of the Brighton Collaboration was followed to develop a consensus definition and define levels of diagnostic certainty, after an exhaustive review of the literature and expert consultation. The document underwent peer review by the Brighton Collaboration Network.
Assuntos
Palavras-chave

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Vacinas / Perda Auditiva Neurossensorial Limite: Humans Idioma: En Ano de publicação: 2020 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Vacinas / Perda Auditiva Neurossensorial Limite: Humans Idioma: En Ano de publicação: 2020 Tipo de documento: Article